Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06149702
Other study ID # Version 3, 31.07.23
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 30, 2023
Est. completion date September 2024

Study information

Verified date November 2023
Source University of Manchester
Contact Jaheeda Gangannagaripalli, PhD
Phone 07449345250
Email jaheeda.gangannagaripalli@manchester.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

"Keep on Keep up (KOKU)" is a tablet/iPad-based, digital strength and balance exercise programme specifically designed for older people at risk of falls. Research has shown that the exercises reduce falls by around a third in older people. People with Dementia are more reluctant and have greater challenges with using digital technologies. Evidence suggests that developing technologies in a Patient-Centered manner will be more acceptable in this population as People with Dementia are more reluctant to using digital technologies. The existing version of the KOKU app has been modified in collaboration with People with Dementia and carers to suit their needs and make it Dementia-friendly and accessible to people with Dementia. The current project involves testing the modified new version of the KOKU app with people with Dementia, their carers, and health and social care professionals. This project will have many possible benefits for people with Dementia; It has the potential to improve quality of life (QoL), well-being, confidence, independence, and therefore has the potential to reduce general practice visits, hospital admissions, and health and social care costs.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date September 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 55 Years to 90 Years
Eligibility Inclusion Criteria: Participant inclusion criteria: PwD and carers of PwD Participants will be selected purposively to derive a maximum variation sample including age, gender, diverse representation from different backgrounds and different levels of Dementia, early cognitive decline and different stages of disease progression thus, increase the external generalisability of the results. - PwD and carers of PwD aged =55 yrs - willing and able to give informed consent (assessed by the trained researchers and/or HSCPs). - who lack capacity to consent themselves but can be supported by a carer or an advocate. - Carers of PwD who lack capacity to consent themselves. - able to speak English. - able to see the tablet/iPad-based app and read instructions with or without glasses. - able to use tablet/iPad safely, as assessed by the trained research staff and/or HSCPs. - able to move indoors without help, and with or without a walking aid. Professionals • HSCPs caring for PwD Exclusion Criteria: PwD - Participants with: - Acute/chronic or uncontrolled medical condition (e.g. severe congestive cardiac failure, uncontrolled hypertension, acute systemic illness, neurological problems, poorly controlled diabetes). - recent fracture or surgery (within 6 months) - orthopaedic surgery (such as hip/knee surgery) in the past six months or on a waiting list to have the surgery. - heart problems such as myocardial infarction or stroke in the past six months - conditions requiring a specialist/exercise programme (e.g., uncontrolled epilepsy, or uses a wheelchair to mobilise indoors). - severe hearing/visual impairment. - any other medical condition likely to compromise the ability to use/access the app. - Participants currently in hospital or care home, - Participants who have limited understanding or ability to speak English, and . - Persons with Dementia who do not have a carer who can provide assent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Keep-on-Keep-Up
Keep-On-Keep-Up (KOKU) programme in the app will be used by the participants for 6 weeks and outcome assessments will be performed at baseline and 6 weeks of use

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Jaheeda Gangannagaripalli

Outcome

Type Measure Description Time frame Safety issue
Primary The feasibility and acceptability of the intervention will be evaluated in terms of recruitment, retention and adherence rates to the trial. 6 weeks
Secondary Quality of life (QoL) as measured by The European Quality of Life 5 Dimensions (EQ-5D-5L) scale. 6 weeks
Secondary The Erlangen Test for Activities of Daily Living test (E-ADL-Test) is a valid and reliable instrument for assessing the ADL capabilities of people with Dementia. 6 weeks
Secondary The Short Physical Performance Battery (SPPB) is a validated and reliable instrument to assess functional mobility in people with cognitive impairment/dementia 6 weeks
Secondary The 5-item Geriatric Depression Scale screening tool for depression in older adults 6 weeks
Secondary Falls risk will be measured with the use of the Assessment of falls risk (FRAT) tool. 6 weeks
Secondary The Short Falls Efficacy Scale-International (FES-I) at the baseline assessment. Baseline
Secondary The User Experience Questionnaire (UEQ) is a standardized 26-item questionnaire that is used reliably to assess the quality and user experience of the interactive products 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT05686486 - Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes N/A
Terminated NCT05451693 - Outreach-ER: A Dementia Care Intervention Program
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Enrolling by invitation NCT06040294 - Dementia and Disability Simulation for College Nursing Students' Senior Activity Facilitation Skills N/A
Completed NCT05114187 - An Internet-Based Education Program for Care Partners of People Living With Dementia N/A
Recruiting NCT06322121 - Vascular Aspects in Dementia: Part 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT04426838 - Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad N/A
Recruiting NCT03462485 - Pilot Study of the Effects of Playing Golf on People With Dementia N/A
Active, not recruiting NCT03677284 - Managing Time With Dementia: Effects of Time Assistive Products in People With Dementia N/A
Completed NCT03849937 - Changing Talk Online (CHATO) Study N/A
Recruiting NCT06284213 - Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT05080777 - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems N/A
Completed NCT04571697 - A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Recruiting NCT06033066 - Financial Incentives and Recruitment to the APT Webstudy N/A
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT05684783 - Dementia Champions in Homecare
Completed NCT03147222 - Function Focused Care: Fracture Care at Home N/A